Have a personal or library account? Click to login
Reply – Clinical Spectrum of Drug-Induced Movement Disorders: A Study of 97 Patients Cover

Reply – Clinical Spectrum of Drug-Induced Movement Disorders: A Study of 97 Patients

Open Access
|Dec 2020

References

  1. 1Response Letter: Clinical Spectrum of Drug-Induced Movement Disorders: A Study of 97 Patients. Tremor and Other Hyperkinetic Movements.
  2. 2Chouksey A, Pandey S. Clinical Spectrum of Drug-Induced Movement Disorders: A Study of 97 Patients. Tremor and Other Hyperkinetic Movements. 2020; 10: 48. DOI: 10.5334/tohm.554
  3. 3Morgan JC, Kurek JA, Davis JL, Sethi KD. Insights into pathophysiology from medication-induced tremor. Tremor Other Hyperkinet Mov. 2017; 7. DOI: 10.5334/tohm.374
  4. 4Yim S, Choi YH, Heo K, et al. A case of dyskinesia after levetiracetam administration. BMC Neurol. 2019; 19: 292. DOI: 10.1186/s12883-019-1519-8
DOI: https://doi.org/10.5334/tohm.591 | Journal eISSN: 2160-8288
Language: English
Submitted on: Nov 27, 2020
Accepted on: Nov 29, 2020
Published on: Dec 28, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2020 Anjali Chouksey, Sanjay Pandey, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.